The neuroprotective mechanism of puerarin in the treatment of acute spinal ischemia-reperfusion injury is linked to cyclin-dependent kinase 5

Neuroscience Letters

Volumn 584, Issue , 2015, Pages 50-55

  Tian, Feng ^a   Xu, Li Hui ^b   Wang, Bin ^a   Tian, Li Jie ^a   Ji, Xiang Lu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG MEDICAL COLLEGE   (China)

Author keywords

Cdk5; Inhibitor; Puerarin; Roscovitine; Spinal ischemia reperfusion

Indexed keywords

CYCLIN DEPENDENT KINASE 5; PROTEIN P25; PUERARIN; ROSCOVITINE; CDK5 PROTEIN, RAT; CDK5R1 PROTEIN, RAT; ISOFLAVONE DERIVATIVE; NEUROPROTECTIVE AGENT; PHOSPHOTRANSFERASE; PURINE DERIVATIVE;

ACUTE DISEASE; ACUTE SPINAL ISCHEMIA REPERFUSION INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA OCCLUSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL NEUROLOGIC DISEASE; MALE; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; RAT; REPERFUSION; REPERFUSION INJURY; SPINAL CORD ISCHEMIA; SPRAGUE DAWLEY RAT; UPREGULATION; ANIMAL; DRUG EFFECTS; ENZYME ACTIVATION; INFARCTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPINAL CORD;

ACUTE DISEASE; ANIMALS; APOPTOSIS; CYCLIN-DEPENDENT KINASE 5; ENZYME ACTIVATION; INFARCTION; ISOFLAVONES; MALE; NEUROPROTECTIVE AGENTS; PHOSPHOTRANSFERASES; PURINES; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SPINAL CORD; SPINAL CORD ISCHEMIA;

EID: 84908628071     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.09.049     Document Type: Article

References (31)

1. Duc S., Delleci C., Barandon L., Nozeres A., Cugy E., Barat M., Dehail P. Complications arising after thoracic aortic surgery: a case report on an unusual spinal cord infarction. Physiopathological and clinical considerations. Ann. Phys. Rehabil. Med. 2013, 56(1):51-62.
2. Geisbüsch S., Stefanovic A., Koruth J.S., Lin H.M., Morgello S., Weisz D.J., Griepp R.B., Di Luozzo G. Endovascular coil embolization of segmental arteries prevents paraplegia after subsequent thoracoabdominal aneurysm repair: an experimental model. J. Thorac. Cardiovasc. Surg. 2013, 147(1):220-226.
3. Sonkar S.K., Gupta A., Atam V., Chaudhary S.C., Tripathi A.K., Sonkar G.K. Clinical profile of neurological manifestation in human immunodeficiency virus-positive patients. N. Am. J. Med. Sci. 2012, 11:596-599.
4. Sang H.F., Mei Q.B., Xu L.X., Wang Q., Cheng H., Xiong L.Z. Effect of puerarin on neural function and histopathological damages after transient spinal cord ischemia in rabbits. Chin. J. Traumatol. 2004, 7(3):143-147.
5. Lee K.H., Morris-Natschke S., Qian K., Dong Y., Yang X., Zhou T., Belding E., Wu S.F., Wada K., Akiyama T. Recent progress of research on herbal products used in traditional Chinese medicine: the herbs belonging to the Divine Husbandman's Herbal Foundation Canon. J. Tradit. Complement. Med. 2012, 2(1):6-26.
6. Wang L., Zhao A., Wang F., Chai Q., Chai X. Protective effect of puerarin on acute cerebral ischemia in rats. Zhongguo Zhong Yao Za Zhi 1997, 22(12):752-754.
7. Xu X., Zhang S., Zhang L., Yan W., Zheng X. The neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. Planta Med. 2005, 71(7):585-591.
8. Singh A.K., Jiang Y., Gupta S., Younus M., Ramzan M. Anti-inflammatory potency of nano-formulated puerarin and curcumin in rats subjected to the lipopolysaccharide-induced inflammation. Med. Food 2013, 16(October (10)):899-911.
9. Wang J.W., Wang H.D., Cong Z.X., Zhou X.M., Xu J.G., Jia Y., Ding Y. Puerarin ameliorates oxidative stress in a rodent model of traumatic brain injury. J. Surg. Res. 2013, pii: S0022-4804(13)00831-7 (Epub ahead of print). 10.1016/j.jss.2013.08.027.
10. Xu X., Zhang S., Zhang L., Yan W., Zheng X. The neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. Planta Med. 2005, 71(July (7)):585-591.
11. Tian F., Xu L.H., Zhao W., Tian L.J., Ji X.L. The neuroprotective mechanism of puerarin treatment of acute spinal cord injury in rats. Neurosci. Lett. 2013, 543:64-68.
12. Sundaram J.R., Poore C.P., Sulaimee N.H.B., Pareek T., Asad A.B.M.A., Rajkumar R., Cheong W.F., Wenk M.R., Dawe G.S., Chuang K.H., Pant H.C., Kesavapany S. Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo. J. Neurosci. 2013, 33(1):334-343.
13. Cruz J.C., Tseng H.C., Goldman J.A., Shih H., Tsai L.H. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 2003, 40:471-483.
14. Sundaram J.R., Chan E.S., Poore C.P., Pareek T.K., Cheong W.F., Shui G., Tang N., Low C.M., Wenk M.R., Kesavapany S. Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration. J. Neurosci. 2012, 32:1020-1034.
15. Taira Y., Marsala M. Effect of proximal arterial perfusion pressure on function, spinal cord blood flow, and histopathologic changes after increasing intervals of aortic occlusion in the rat. Stroke 1996, 27:1850-1858.
16. Kakinohana M., Nakamura S., Fuchigami T., Sugahara K. Transcranial motor-evoked potentials monitoring can detect spinal cord ischemia more rapidly than spinal cord-evoked potentials monitoring during aortic occlusion in rats. Eur. Spine J. 2007, 16:787-793.
17. Johnson S.H., Kraimer J.M., Graeber G.M. Effects of flunarizine on neurological recovery and spinal cord blood flow in experimental spinal cord ischemia in rabbits. Stroke 1993, 24(10):1547-1553.
18. Fan L., Wang K., Shi Z., Die J., Wang C., Dang X. Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury. J. Vasc. Surg. 2011, 54(1):192-200.
19. Patrick G.N., Zukerberg L., de la Nikolic M.M.S., Dikkes P., Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999, 402:615-622.
20. Korkmaz K., Gedik H.S., Budak A.B., Erdem H., Lafci G., Karakilic E., Nacar O.A., Yildirim L., Ankarali H. Effect of heparin on neuroprotection against spinal cord ischemia and reperfusion in rats. Eur. Rev. Med. Pharmacol. Sci. 2013, 17:522-530.
21. Lou J., Lenke L.G., Ludwig F.J., O'Brien M.F. Apoptosis as a mechanism of neuronal cell death following acute experimental spinal cord injury. Spinal Cord 1998, 36:683-690.
22. Dhavan R., Tsai L.H. A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2001, 2:749-759.
23. Bu B., Li J., Davies P., Vincent I. Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J. Neurosci. 2002, 22:6515-6525.
24. Nguyen M.D., Lariviere R.C., Julien J.P. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 2001, 30:135-147.
25. Cheung Z.H., Fu A.K., Ip N.Y. Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases. Neuron 2006, 50:13-18.
26. Smith D.S., Tsai L.H. Cdk5 behind the wheel: a role in trafficking and transport. Trends Cell Biol. 2002, 12:28-36.
27. Amin N.D., Albers W., Pant H.C. Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35. J. Neurosci. Res. 2002, 67:354-362.
28. Zheng Y.L., Kesavapany S., Gravell M., Hamilton R.S., Schubert M., Amin N., Albers W., Grant P., Pant H.C. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J. 2005, 24:209-220.
29. Eweka A.O., Eweka A., Om'Iniabohs F.A.E. Histological studies of the effects of monosodium glutamate of the Fallopian tubes of adult female Wistar rats. N. Am. J. Med. Sci. 2010, 2(3):146-149.
30. 4 and paracetamol induced hepatotoxicity in adult Wistar rats. N. Am. J. Med. Sci. 2010, 2(10):491-495.
31. Ewing G.W. Mathematical modeling the neuroregulation of blood pressure using a cognitive top-down approach. N. Am. J. Med. Sci. 2010, 2(8):341-352.